Cargando…

Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction

Cellular transformation is associated with altered glutamine (Gln) metabolism. Tumor cells utilize Gln in the tricarboxylic acid (TCA) cycle to maintain sufficient pools of biosynthetic precursors to support rapid growth and proliferation. However, Gln metabolism also generates NADPH, and Gln-derive...

Descripción completa

Detalles Bibliográficos
Autores principales: Cetinbas, Naniye, Daugaard, Mads, Mullen, Andrew, Hajee, Shamil, Rotblat, Barak, Lopez, Alejandra, Li, Amy, DeBerardinis, Ralph J, Sorensen, Poul H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387113/
https://www.ncbi.nlm.nih.gov/pubmed/25284589
http://dx.doi.org/10.1038/onc.2014.316
_version_ 1782365230193442816
author Cetinbas, Naniye
Daugaard, Mads
Mullen, Andrew
Hajee, Shamil
Rotblat, Barak
Lopez, Alejandra
Li, Amy
DeBerardinis, Ralph J
Sorensen, Poul H
author_facet Cetinbas, Naniye
Daugaard, Mads
Mullen, Andrew
Hajee, Shamil
Rotblat, Barak
Lopez, Alejandra
Li, Amy
DeBerardinis, Ralph J
Sorensen, Poul H
author_sort Cetinbas, Naniye
collection PubMed
description Cellular transformation is associated with altered glutamine (Gln) metabolism. Tumor cells utilize Gln in the tricarboxylic acid (TCA) cycle to maintain sufficient pools of biosynthetic precursors to support rapid growth and proliferation. However, Gln metabolism also generates NADPH, and Gln-derived glutamate is used for synthesis of glutathione (GSH). Since both NADPH and GSH are antioxidants, Gln may also contribute to redox balance in transformed cells. The Hace1 E3 ligase is a tumor suppressor inactivated in diverse human cancers. Hace1 targets the Rac1 GTPase for degradation at Rac1-dependent NADPH oxidase complexes, blocking superoxide generation by the latter. Consequently, loss of Hace1 increases reactive oxygen species (ROS) levels in vitro and in vivo. Given the link between Hace1 loss and increased ROS, we investigated whether genetic inactivation of Hace1 alters Gln metabolism. We demonstrate that mouse embryonic fibroblasts (MEFs) derived from Hace1-/- mice are highly sensitive to Gln withdrawal, leading to enhanced cell death compared to wild type (wt) MEFs, and Gln depletion or chemical inhibition of Gln uptake block soft agar colony formation by Hace1-/- MEFs. Hace1-/- MEFs exhibit increased Gln uptake and ammonia secretion, and metabolic labeling using (13)C-Gln revealed that Hace1 loss increases incorporation of Gln carbons into TCA cycle intermediates. Gln starvation markedly increases ROS levels in Hace1-/- but not in wt MEFs, and treatment with the antioxidant N-acetyl cysteine (NAC) or the TCA cycle intermediate oxaloacetate efficiently rescues Gln starvation-induced ROS elevation and cell death in Hace1-/- MEFs. Finally, Gln starvation increases superoxide levels in Hace1-/- MEFs, and NADPH oxidase inhibitors block the induction of superoxide and cell death by Gln starvation. Together, these results suggest that increased ROS production due to Hace1 loss leads to Gln addiction as a mechanism to cope with increased ROS-induced oxidative stress.
format Online
Article
Text
id pubmed-4387113
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-43871132016-01-23 Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction Cetinbas, Naniye Daugaard, Mads Mullen, Andrew Hajee, Shamil Rotblat, Barak Lopez, Alejandra Li, Amy DeBerardinis, Ralph J Sorensen, Poul H Oncogene Article Cellular transformation is associated with altered glutamine (Gln) metabolism. Tumor cells utilize Gln in the tricarboxylic acid (TCA) cycle to maintain sufficient pools of biosynthetic precursors to support rapid growth and proliferation. However, Gln metabolism also generates NADPH, and Gln-derived glutamate is used for synthesis of glutathione (GSH). Since both NADPH and GSH are antioxidants, Gln may also contribute to redox balance in transformed cells. The Hace1 E3 ligase is a tumor suppressor inactivated in diverse human cancers. Hace1 targets the Rac1 GTPase for degradation at Rac1-dependent NADPH oxidase complexes, blocking superoxide generation by the latter. Consequently, loss of Hace1 increases reactive oxygen species (ROS) levels in vitro and in vivo. Given the link between Hace1 loss and increased ROS, we investigated whether genetic inactivation of Hace1 alters Gln metabolism. We demonstrate that mouse embryonic fibroblasts (MEFs) derived from Hace1-/- mice are highly sensitive to Gln withdrawal, leading to enhanced cell death compared to wild type (wt) MEFs, and Gln depletion or chemical inhibition of Gln uptake block soft agar colony formation by Hace1-/- MEFs. Hace1-/- MEFs exhibit increased Gln uptake and ammonia secretion, and metabolic labeling using (13)C-Gln revealed that Hace1 loss increases incorporation of Gln carbons into TCA cycle intermediates. Gln starvation markedly increases ROS levels in Hace1-/- but not in wt MEFs, and treatment with the antioxidant N-acetyl cysteine (NAC) or the TCA cycle intermediate oxaloacetate efficiently rescues Gln starvation-induced ROS elevation and cell death in Hace1-/- MEFs. Finally, Gln starvation increases superoxide levels in Hace1-/- MEFs, and NADPH oxidase inhibitors block the induction of superoxide and cell death by Gln starvation. Together, these results suggest that increased ROS production due to Hace1 loss leads to Gln addiction as a mechanism to cope with increased ROS-induced oxidative stress. 2014-10-06 2015-07-23 /pmc/articles/PMC4387113/ /pubmed/25284589 http://dx.doi.org/10.1038/onc.2014.316 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Cetinbas, Naniye
Daugaard, Mads
Mullen, Andrew
Hajee, Shamil
Rotblat, Barak
Lopez, Alejandra
Li, Amy
DeBerardinis, Ralph J
Sorensen, Poul H
Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
title Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
title_full Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
title_fullStr Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
title_full_unstemmed Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
title_short Loss of the tumor suppressor Hace1 leads to ROS-dependent glutamine addiction
title_sort loss of the tumor suppressor hace1 leads to ros-dependent glutamine addiction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387113/
https://www.ncbi.nlm.nih.gov/pubmed/25284589
http://dx.doi.org/10.1038/onc.2014.316
work_keys_str_mv AT cetinbasnaniye lossofthetumorsuppressorhace1leadstorosdependentglutamineaddiction
AT daugaardmads lossofthetumorsuppressorhace1leadstorosdependentglutamineaddiction
AT mullenandrew lossofthetumorsuppressorhace1leadstorosdependentglutamineaddiction
AT hajeeshamil lossofthetumorsuppressorhace1leadstorosdependentglutamineaddiction
AT rotblatbarak lossofthetumorsuppressorhace1leadstorosdependentglutamineaddiction
AT lopezalejandra lossofthetumorsuppressorhace1leadstorosdependentglutamineaddiction
AT liamy lossofthetumorsuppressorhace1leadstorosdependentglutamineaddiction
AT deberardinisralphj lossofthetumorsuppressorhace1leadstorosdependentglutamineaddiction
AT sorensenpoulh lossofthetumorsuppressorhace1leadstorosdependentglutamineaddiction